オピオイドアゴニスト薬の世界市場 2021年:メーカー別、地域別、種類・用途別

◆英語タイトル:Global Opioids Agonist Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
◆商品コード:GIR21AR10261
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2021年4月
◆ページ数:101
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後2~3日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥574,200見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥765,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalInfoResearch社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalInfoResearch社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

GlobalInfoResearch社の本調査レポートでは、オピオイドアゴニスト薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。オピオイドアゴニスト薬の種類別市場規模(コデイン、フェンタニル、メペリジン、メタドン、モルヒネ、ヒドロコドン)、用途別市場規模(痛み管理、咳治療、下痢治療)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(企業概要、製品概要、販売量、価格、売上):Purdue Pharma、Titan pharmaceuticals、Boehringer Ingelheim、Janssen Pharmaceuticals, Inc、Sanofi、Sun Pharmaceuticals、Mallinckrodt Pharmaceuticals、Egalet Corporation、Endo Pharmaceuticals Inc.、Allergan, Plc、Pfizer Inc
・メーカー別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:コデイン、フェンタニル、メペリジン、メタドン、モルヒネ、ヒドロコドン
・用途別分析2016年-2026年:痛み管理、咳治療、下痢治療
・オピオイドアゴニスト薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・オピオイドアゴニスト薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・オピオイドアゴニスト薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・オピオイドアゴニスト薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・オピオイドアゴニスト薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
【レポートの概要】

The Opioids Agonist Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Opioids Agonist Drugs size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Opioids Agonist Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Opioids Agonist Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Codeine
Fentanyl
Meperidine
Methadone
Morphine
Hydrocodone

Market segment by Application can be divided into
Pain Management
Cough Treatment
Diarrhea Treatment

The key market players for global Opioids Agonist Drugs market are listed below:
Purdue Pharma
Titan pharmaceuticals
Boehringer Ingelheim
Janssen Pharmaceuticals, Inc
Sanofi
Sun Pharmaceuticals
Mallinckrodt Pharmaceuticals
Egalet Corporation
Endo Pharmaceuticals Inc.
Allergan, Plc
Pfizer Inc

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

【レポートの目次】

1 Market Overview
1.1 Opioids Agonist Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Opioids Agonist Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Codeine
1.2.3 Fentanyl
1.2.4 Meperidine
1.2.5 Methadone
1.2.6 Morphine
1.2.7 Hydrocodone
1.3 Market Analysis by Application
1.3.1 Overview: Global Opioids Agonist Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pain Management
1.3.3 Cough Treatment
1.3.4 Diarrhea Treatment
1.4 Global Opioids Agonist Drugs Market Size & Forecast
1.4.1 Global Opioids Agonist Drugs Sales in Value (2016-2026))
1.4.2 Global Opioids Agonist Drugs Sales in Volume (2016-2026)
1.4.3 Global Opioids Agonist Drugs Price by Type (2016-2026) & (USD/Unit)
1.5 Global Opioids Agonist Drugs Production Capacity Analysis
1.5.1 Global Opioids Agonist Drugs Total Production Capacity (2016-2026)
1.5.2 Global Opioids Agonist Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Opioids Agonist Drugs Market Drivers
1.6.2 Opioids Agonist Drugs Market Restraints
1.6.3 Opioids Agonist Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Purdue Pharma
2.1.1 Purdue Pharma Details
2.1.2 Purdue Pharma Major Business
2.1.3 Purdue Pharma Opioids Agonist Drugs Product and Services
2.1.4 Purdue Pharma Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Titan pharmaceuticals
2.2.1 Titan pharmaceuticals Details
2.2.2 Titan pharmaceuticals Major Business
2.2.3 Titan pharmaceuticals Opioids Agonist Drugs Product and Services
2.2.4 Titan pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Opioids Agonist Drugs Product and Services
2.3.4 Boehringer Ingelheim Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Janssen Pharmaceuticals, Inc
2.4.1 Janssen Pharmaceuticals, Inc Details
2.4.2 Janssen Pharmaceuticals, Inc Major Business
2.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
2.4.4 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Sanofi
2.5.1 Sanofi Details
2.5.2 Sanofi Major Business
2.5.3 Sanofi Opioids Agonist Drugs Product and Services
2.5.4 Sanofi Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Sun Pharmaceuticals
2.6.1 Sun Pharmaceuticals Details
2.6.2 Sun Pharmaceuticals Major Business
2.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
2.6.4 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Mallinckrodt Pharmaceuticals
2.7.1 Mallinckrodt Pharmaceuticals Details
2.7.2 Mallinckrodt Pharmaceuticals Major Business
2.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
2.7.4 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Egalet Corporation
2.8.1 Egalet Corporation Details
2.8.2 Egalet Corporation Major Business
2.8.3 Egalet Corporation Opioids Agonist Drugs Product and Services
2.8.4 Egalet Corporation Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Endo Pharmaceuticals Inc.
2.9.1 Endo Pharmaceuticals Inc. Details
2.9.2 Endo Pharmaceuticals Inc. Major Business
2.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
2.9.4 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Allergan, Plc
2.10.1 Allergan, Plc Details
2.10.2 Allergan, Plc Major Business
2.10.3 Allergan, Plc Opioids Agonist Drugs Product and Services
2.10.4 Allergan, Plc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Pfizer Inc
2.11.1 Pfizer Inc Details
2.11.2 Pfizer Inc Major Business
2.11.3 Pfizer Inc Opioids Agonist Drugs Product and Services
2.11.4 Pfizer Inc Opioids Agonist Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Opioids Agonist Drugs Sales by Manufacturer
3.1 Global Opioids Agonist Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Opioids Agonist Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Opioids Agonist Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Opioids Agonist Drugs Manufacturer Market Share
3.4.2 Top 6 Opioids Agonist Drugs Manufacturer Market Share
3.5 Global Opioids Agonist Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Opioids Agonist Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Opioids Agonist Drugs Market Size by Region
4.1.1 Global Opioids Agonist Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Opioids Agonist Drugs Revenue by Region (2016-2026)
4.2 North America Opioids Agonist Drugs Revenue (2016-2026)
4.3 Europe Opioids Agonist Drugs Revenue (2016-2026)
4.4 Asia-Pacific Opioids Agonist Drugs Revenue (2016-2026)
4.5 South America Opioids Agonist Drugs Revenue (2016-2026)
4.6 Middle East and Africa Opioids Agonist Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Opioids Agonist Drugs Sales in Volume by Type (2016-2026)
5.2 Global Opioids Agonist Drugs Revenue by Type (2016-2026)
5.3 Global Opioids Agonist Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Opioids Agonist Drugs Sales in Volume by Application (2016-2026)
6.2 Global Opioids Agonist Drugs Revenue by Application (2016-2026)
6.3 Global Opioids Agonist Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Opioids Agonist Drugs Sales by Type (2016-2026)
7.2 North America Opioids Agonist Drugs Sales by Application (2016-2026)
7.3 North America Opioids Agonist Drugs Market Size by Country
7.3.1 North America Opioids Agonist Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Opioids Agonist Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Opioids Agonist Drugs Sales by Type (2016-2026)
8.2 Europe Opioids Agonist Drugs Sales by Application (2016-2026)
8.3 Europe Opioids Agonist Drugs Market Size by Country
8.3.1 Europe Opioids Agonist Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Opioids Agonist Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Opioids Agonist Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Opioids Agonist Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Opioids Agonist Drugs Market Size by Region
9.3.1 Asia-Pacific Opioids Agonist Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Opioids Agonist Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Opioids Agonist Drugs Sales by Type (2016-2026)
10.2 South America Opioids Agonist Drugs Sales by Application (2016-2026)
10.3 South America Opioids Agonist Drugs Market Size by Country
10.3.1 South America Opioids Agonist Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Opioids Agonist Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Opioids Agonist Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Opioids Agonist Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Opioids Agonist Drugs Market Size by Country
11.3.1 Middle East & Africa Opioids Agonist Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Opioids Agonist Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Opioids Agonist Drugs Typical Distributors
12.3 Opioids Agonist Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Opioids Agonist Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Opioids Agonist Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Purdue Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Purdue Pharma Major Business
Table 5. Purdue Pharma Opioids Agonist Drugs Product and Services
Table 6. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Titan pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 8. Titan pharmaceuticals Major Business
Table 9. Titan pharmaceuticals Opioids Agonist Drugs Product and Services
Table 10. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 12. Boehringer Ingelheim Major Business
Table 13. Boehringer Ingelheim Opioids Agonist Drugs Product and Services
Table 14. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Janssen Pharmaceuticals, Inc Basic Information, Manufacturing Base and Competitors
Table 16. Janssen Pharmaceuticals, Inc Major Business
Table 17. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product and Services
Table 18. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Sanofi Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi Major Business
Table 21. Sanofi Opioids Agonist Drugs Product and Services
Table 22. Sanofi Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Sun Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Sun Pharmaceuticals Major Business
Table 25. Sun Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 26. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mallinckrodt Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Mallinckrodt Pharmaceuticals Major Business
Table 29. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product and Services
Table 30. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Egalet Corporation Basic Information, Manufacturing Base and Competitors
Table 32. Egalet Corporation Major Business
Table 33. Egalet Corporation Opioids Agonist Drugs Product and Services
Table 34. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Endo Pharmaceuticals Inc. Basic Information, Manufacturing Base and Competitors
Table 36. Endo Pharmaceuticals Inc. Major Business
Table 37. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product and Services
Table 38. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Allergan, Plc Basic Information, Manufacturing Base and Competitors
Table 40. Allergan, Plc Major Business
Table 41. Allergan, Plc Opioids Agonist Drugs Product and Services
Table 42. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Pfizer Inc Basic Information, Manufacturing Base and Competitors
Table 44. Pfizer Inc Major Business
Table 45. Pfizer Inc Opioids Agonist Drugs Product and Services
Table 46. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Opioids Agonist Drugs Sales by Manufacturer (2019-2021e) & (K Units)
Table 48. Global Opioids Agonist Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Opioids Agonist Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Opioids Agonist Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 51. Head Office and Opioids Agonist Drugs Production Site of Key Manufacturer
Table 52. Global Opioids Agonist Drugs Sales by Region (2016-2021e) & (K Units)
Table 53. Global Opioids Agonist Drugs Sales by Region (2021-2026) & (K Units)
Table 54. Global Opioids Agonist Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Opioids Agonist Drugs Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 57. Global Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 58. Global Opioids Agonist Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Opioids Agonist Drugs Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Opioids Agonist Drugs Price by Type (2016-2021e) & (USD/Unit)
Table 61. Global Opioids Agonist Drugs Price by Type (2021-2026) & (USD/Unit)
Table 62. Global Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 63. Global Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 64. Global Opioids Agonist Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Opioids Agonist Drugs Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Opioids Agonist Drugs Price by Application (2016-2021e) & (USD/Unit)
Table 67. Global Opioids Agonist Drugs Price by Application (2021-2026) & (USD/Unit)
Table 68. North America Opioids Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 69. North America Opioids Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 70. North America Opioids Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Opioids Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 73. North America Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 74. North America Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 75. North America Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 76. Europe Opioids Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 77. Europe Opioids Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 78. Europe Opioids Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Opioids Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 81. Europe Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 82. Europe Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 83. Europe Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 84. Asia-Pacific Opioids Agonist Drugs Sales by Region (2016-2021e) & (K Units)
Table 85. Asia-Pacific Opioids Agonist Drugs Sales by Region (2021-2026) & (K Units)
Table 86. Asia-Pacific Opioids Agonist Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Opioids Agonist Drugs Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 89. Asia-Pacific Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 90. Asia-Pacific Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 91. Asia-Pacific Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 92. South America Opioids Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 93. South America Opioids Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 94. South America Opioids Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Opioids Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 97. South America Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 98. South America Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 99. South America Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 100. Middle East & Africa Opioids Agonist Drugs Sales by Country (2016-2021e) & (K Units)
Table 101. Middle East & Africa Opioids Agonist Drugs Sales by Country (2021-2026) & (K Units)
Table 102. Middle East & Africa Opioids Agonist Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Opioids Agonist Drugs Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Opioids Agonist Drugs Sales by Type (2016-2021e) & (K Units)
Table 105. Middle East & Africa Opioids Agonist Drugs Sales by Type (2021-2026) & (K Units)
Table 106. Middle East & Africa Opioids Agonist Drugs Sales by Application (2016-2021e) & (K Units)
Table 107. Middle East & Africa Opioids Agonist Drugs Sales by Application (2021-2026) & (K Units)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Opioids Agonist Drugs Typical Distributors
Table 111. Opioids Agonist Drugs Typical Customers
List of Figures
Figure 1. Opioids Agonist Drugs Picture
Figure 2. Global Opioids Agonist Drugs Sales Market Share by Type in 2020
Figure 3. Codeine
Figure 4. Fentanyl
Figure 5. Meperidine
Figure 6. Methadone
Figure 7. Morphine
Figure 8. Hydrocodone
Figure 9. Global Opioids Agonist Drugs Sales Market Share by Application in 2020
Figure 10. Pain Management
Figure 11. Cough Treatment
Figure 12. Diarrhea Treatment
Figure 13. Global Opioids Agonist Drugs Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 14. Global Opioids Agonist Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 15. United States Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Canada Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Mexico Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Germany Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. France Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. United Kingdom Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Russia Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Italy Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. China Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Japan Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Korea Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. India Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Southeast Asia Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Australia Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Brazil Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Egypt Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Saudi Arabia Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. South Africa Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Turkey Opioids Agonist Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. Global Opioids Agonist Drugs Sales (2016-2026) & (K Units)
Figure 35. Global Opioids Agonist Drugs Production Capacity (2016-2026) & (K Units)
Figure 36. Global Opioids Agonist Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 37. Opioids Agonist Drugs Market Drivers
Figure 38. Opioids Agonist Drugs Market Restraints
Figure 39. Opioids Agonist Drugs Market Trends
Figure 40. Global Opioids Agonist Drugs Sales Market Share by Manufacturer in 2020
Figure 41. Global Opioids Agonist Drugs Revenue Market Share by Manufacturer in 2020
Figure 42. Opioids Agonist Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 43. Top 3 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2020
Figure 44. Top 6 Opioids Agonist Drugs Manufacturer (Revenue) Market Share in 2020
Figure 45. Global Opioids Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 46. Global Opioids Agonist Drugs Revenue Market Share by Region (2016-2026)
Figure 47. North America Opioids Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 48. Europe Opioids Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 49. Asia-Pacific Opioids Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 50. South America Opioids Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 51. Middle East & Africa Opioids Agonist Drugs Revenue (2016-2026) & (USD Million)
Figure 52. Global Opioids Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 53. Global Opioids Agonist Drugs Revenue Market Share by Type (2016-2026)
Figure 54. Global Opioids Agonist Drugs Price by Type (2016-2026) & (USD/Unit)
Figure 55. Global Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 56. Global Opioids Agonist Drugs Revenue Market Share by Application (2016-2026)
Figure 57. Global Opioids Agonist Drugs Price by Application (2016-2026) & (USD/Unit)
Figure 58. North America Opioids Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 59. North America Opioids Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 60. North America Opioids Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 61. North America Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 62. Europe Opioids Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 63. Europe Opioids Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 64. Europe Opioids Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 65. Europe Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 66. Asia-Pacific Opioids Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Opioids Agonist Drugs Revenue Market Share by Region (2016-2026)
Figure 68. Asia-Pacific Opioids Agonist Drugs Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 70. South America Opioids Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 71. South America Opioids Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 72. South America Opioids Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 73. South America Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 74. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country (2016-2026)
Figure 75. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country (2016-2026)
Figure 76. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Type (2016-2026)
Figure 77. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Application (2016-2026)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


【掲載企業】

Purdue Pharma、Titan pharmaceuticals、Boehringer Ingelheim、Janssen Pharmaceuticals, Inc、Sanofi、Sun Pharmaceuticals、Mallinckrodt Pharmaceuticals、Egalet Corporation、Endo Pharmaceuticals Inc.、Allergan, Plc、Pfizer Inc

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[オピオイドアゴニスト薬の世界市場 2021年:メーカー別、地域別、種類・用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆